Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Kisspeptin LH/FSH Release: Mechanism Comparison

Understanding how kisspeptin-driven LH/FSH release differs from other reproductive hormone triggers clarifies its unique role in HPG axis regulation. Kisspeptin (pulsatile) GnRH neurons in arcuate nucleus Pulsatile LH release every 60–120 min; moderate FSH ele

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Understanding how kisspeptin-driven LH/FSH release differs from other reproductive hormone triggers clarifies its unique role in HPG axis regulation.
  • Kisspeptin (pulsatile)
  • GnRH neurons in arcuate nucleus
  • Pulsatile LH release every 60–120 min; moderate FSH elevation
  • 60–90 min per pulse
  • Maintains baseline reproductive hormone levels; mimics physiological GnRH drive
  • Most physiological method to stimulate endogenous LH/FSH without receptor desensitization
  • Kisspeptin (surge-mode)
  • GnRH neurons in AVPV
  • High-amplitude LH surge (10–20× baseline); minimal FSH change
  • 12–24 hours
  • Triggers ovulation in females; requires prior estradiol priming
  • Replicates mid-cycle LH surge mechanism; not applicable in males
  • Exogenous GnRH (pulsatile)
  • Gonadotroph cells in anterior pituitary
  • Pulsatile LH and FSH release; ratio depends on pulse frequency
  • Used in GnRH pump therapy for hypogonadotropic hypogonadism
  • Bypasses kisspeptin-GnRH step; effective but requires subcutaneous pump for pulsatility
  • Exogenous GnRH (continuous)
  • Initial LH/FSH surge, then suppression within 7–14 days
  • Suppression persists during continuous administration
  • GnRH agonist therapy for prostate cancer, endometriosis, precocious puberty
  • Paradoxical downregulation. Used to suppress, not stimulate, the HPG axis
  • Human chorionic gonadotropin (hCG)
  • LH receptors on Leydig cells (males) or corpus luteum (females)
  • No LH/FSH elevation (bypasses pituitary); directly stimulates gonadal steroidogenesis
  • 48–72 hours
  • Fertility treatment; maintains testosterone during anabolic steroid use
  • Mimics LH action directly; does not restore pituitary LH/FSH secretion
  • Kisspeptin uniquely stimulates the endogenous GnRH pulse generator without causing receptor desensitization, provided administration is pulsatile rather than continuous. This makes it the most physiological approach to restoring LH/FSH secretion in conditions where kisspeptin neuron activity is impaired but downstream GnRH and pituitary function remain intact.